Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Catheter Precision, Inc. Common Stock (NY:VTAK)

0.2317 +0.0017 (+0.74%)
Streaming Delayed Price Updated: 10:01 AM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Catheter Precision, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
Market Movers on The Street: LAZR, INBS, REBN, PSRO
Via AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Announces Purchase Order From University of California San Diego (UCSD) Health System
Via AB Newswire
Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS
Via AB Newswire
Catheter Precision, Inc. (VTAK) Announces Receipt of New Purchase Order and Product Evaluation at New Hospital
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE-American: VTAK) Announces New Chief Commercial Officer
Via ACCESSWIRE
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
Via AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Stock Surges Following LockeT Purchase Order from HCA Healthcare
Via AB Newswire
Stocks Creating Buzz Look Now: VTAK, AMST, HOOK, MULN, KAVL
Via AB Newswire
Topics Artificial Intelligence
Catheter Precision, Inc. (VTAK) Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility
Via ACCESSWIRE
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
Via AB Newswire
Medical Device Innovator Catheter Precision Inc. (NYSE American: VTAK) Gains Momentum with LockeT and VIVO™ Products – Full Analysis Inside!
Via AB Newswire
Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB
Via AB Newswire
Topics Intellectual Property
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates ‘Buy’ for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN
Via AB Newswire
Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements
Via AB Newswire
Catheter Precision (NYSE American: VTAK) Shows Fiscal Strength, Solid Growth and Strategic Moves; Bullish Momentum Seen in Stock Price
Via AB Newswire
Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Releases Operational Performance Report, Q4 and Annual 2023 Financials for Year Ending December 31, 2023
Via ACCESSWIRE
March Madness 2024: Key Players in Medical Tech, Healthcare and AI: INBS, AMTX, VTAK, ANGH, TRUG
Via AB Newswire
Topics Energy
Catheter Precision Inc. (NYSE American: VTAK) Surges with VIVO™ Success
Via AB Newswire
Catheter Precision, Inc. (NYSE American:VTAK) to Sponsor the Monaco USA Arrhythmia Course
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First use of VIVO in Qatar
Via ACCESSWIRE
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
Via AB Newswire
Market Spotlight: Catheter Precision Inc (NYSE American: VTAK) Emerges as a Key Stock to Watch
Via AB Newswire
Catheter Precision, Inc. (NYSE American: VTAK) Announces the First use of LockeT Outside of the United States
Via ACCESSWIRE
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
Medical Innovations Spotlight: Catheter Precision’s VIVO™ Revolutionizes Cardiac Procedures
Via AB Newswire
Catheter Precision Inc (NYSE American: VTAK) Marks Milestone: VIVO Used Successfully with Pediatric Patient
Via AB Newswire
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB
Via AB Newswire
Topics Intellectual Property
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First Use of VIVO With a Pediatric Patient in Turkey
Via ACCESSWIRE
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.